Financials Celanese Corporation

Stocks

CE

US1508701034

Specialty Chemicals

Market Closed - 16:00:02 2026-10-30 EDT 5-day change 1st Jan Change
49.30 USD +2.03% Intraday chart for Celanese Corporation +3.33% +16.60%

Projected Income Statement: Celanese Corporation

Forecast Balance Sheet: Celanese Corporation

Forecast Balance Sheet - Celanese Corporation
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Net Debt 1 3,431 13,171 11,879 11,617 11,335 10,173 9,395 8,408
Change - 283.88% -9.81% -2.21% -2.43% -10.25% -7.65% -10.51%
Announcement Date 1/27/22 2/23/23 2/20/24 2/18/25 2/17/26 - - -
1USD in Million
Estimates

Cash Flow Forecast: Celanese Corporation

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
CAPEX 1 467 543 568 435 343 312.5 369.9 386.3
Change - 16.27% 4.6% -23.42% -21.15% -8.88% 18.35% 4.44%
Free Cash Flow (FCF) 1 1,290 1,276 1,320 498 773 766.2 813.3 901.9
Change - -1.09% 3.45% -62.27% 55.22% -0.88% 6.14% 10.9%
Announcement Date 1/27/22 2/23/23 2/20/24 2/18/25 2/17/26 - - -
1USD in Million
Estimates

Forecast Financial Ratios: Celanese Corporation

Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028

Profitability

        
EBITDA Margin (%) 33.21% 27.05% 22.34% 23.11% 19.83% 21.32% 21.08% 21.69%
EBIT Margin (%) 28.97% 22.44% 16.02% 16.03% 12.05% 13.96% 13.94% 14.51%
EBT Margin (%) 26.33% 14.69% 10.81% -9.69% -12.78% 5.54% 6.44% 7.75%
Net margin (%) 22.14% 19.58% 17.92% -14.81% -12.21% 4.69% 5.88% 6.81%
FCF margin (%) 15.11% 13.19% 12.07% 4.84% 8.1% 7.65% 8.18% 8.82%
FCF / Net Income (%) 68.25% 67.37% 67.35% -32.72% -66.35% 163.14% 139.26% 129.57%

Profitability

        
ROA 16.52% 9.07% 3.69% 3.7% 1.96% 2.79% 2.97% 3.79%
ROE 52.65% 35.29% 15.34% 14.92% 9.52% 15.22% 14.37% 15.21%

Financial Health

        
Leverage (Debt/EBITDA) 1.21x 5.03x 4.86x 4.89x 5.99x 4.77x 4.49x 3.79x
Debt / Free cash flow 2.66x 10.32x 9x 23.33x 14.66x 13.28x 11.55x 9.32x

Capital Intensity

        
CAPEX / Current Assets (%) 5.47% 5.61% 5.19% 4.23% 3.59% 3.12% 3.72% 3.78%
CAPEX / EBITDA (%) 16.47% 20.75% 23.24% 18.31% 18.12% 14.64% 17.66% 17.43%
CAPEX / FCF (%) 36.2% 42.55% 43.03% 87.35% 44.37% 40.79% 45.48% 42.83%

Items per share

        
Cash flow per share 1 15.67 16.66 17.36 8.838 10.45 10.04 11.42 13
Change - 6.28% 4.21% -49.08% 18.2% -3.88% 13.74% 13.81%
Dividend per Share 1 2.72 2.74 2.8 2.8 0.12 0.1206 0.1229 0.126
Change - 0.74% 2.19% 0% -95.71% 0.53% 1.84% 2.56%
Book Value Per Share 1 38.78 51.97 64.82 47.35 36.98 41.89 46.37 51.86
Change - 34.01% 24.73% -26.95% -21.9% 13.29% 10.69% 11.83%
EPS 1 16.86 17.34 17.92 -13.93 -10.64 4.354 5.205 6.086
Change - 2.85% 3.34% -177.73% 23.62% 140.92% 19.54% 16.92%
Nbr of stocks (in thousands) 108,871 108,428 108,855 109,312 109,505 109,749 109,749 109,749
Announcement Date 1/27/22 2/23/23 2/20/24 2/18/25 2/17/26 - - -
1USD
Estimates
2026 *2027 *
P/E 11.3x 9.47x
PBR 1.18x 1.06x
EV / Sales 1.56x 1.49x
Yield 0.24% 0.25%

EPS & Dividend

EPS & Dividend - Celanese Corporation


Y-o-Y evolution of P/E

Valuation ratios - P/E - Celanese Corporation
 

Year-on-year evolution of the Yield

Valuation ratios - Yield - Celanese Corporation
Trader
Investor
Global
Quality
ESG MSCI
BBB
MarketScreener Ratings - Celanese Corporation
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
49.30USD
Average target price
61.17USD
Spread / Average Target
+24.07%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Celanese Corporation
  1. Stock Market
  2. Stocks
  3. CE Stock
  4. Financials Celanese Corporation